Utama › Fibrosis Paru Idiopatik › Missouri
Kajian klinikal Fibrosis Paru Idiopatik di Missouri
6 kajian untuk Fibrosis Paru Idiopatik sedang mencari peserta di lokasi di Missouri.
Teks kajian rasmi (Bahasa Inggeris)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Hannibal Regional Healthcare System, Inc., Hannibal
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06951217A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Healthcare System, Inc., Hannibal
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07516951Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Hannibal Regional Hospital, Hannibal
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- The Lung Research Center, LLC, Chesterfield
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Hospital /ID# 277984, Hannibal
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07230288Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Washington University, St Louis
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.